Teofilina nas apnéias e respiraçöes periódicas neonatais: avaliaçäo poligráfica

Reimäo, Rubens; Lemmi, Helio; Sander, Craig; Zwaag, Roger Vander; Hamlett III, James.
Rev. paul. med ; 104(1): 15-7, jan.-fev. 1986. tab
Artículo en Portugués | LILACS | ID: lil-33786

Documentos relacionados

  1. Caffeine versus other methylxanthines for the prevention and treatment of apnea in preterm infants.
  2. Treatment of apnea and excessive periodic breathing in the full-term infant.
  3. One step closer to pharmacotherapy for sleep apnoea.
  4. The limited management options for apnoea of prematurity.
  5. [Clinical effect and safety of different maintenance doses of caffeine citrate in treatment of apnea in very low birth weight preterm infants: a prospective randomized controlled trial].
  6. A Randomized Controlled Clinical Trial Exploring Safety and Tolerability of Sulthiame in Sleep Apnea.
  7. [Sleep-Disordered Breathing at High Altitude: Its Characteristics and Research Progress in Treatment].
  8. Brainstem depolarization-induced lethal apnea associated with gain-of-function <i>SCN1A</i><sup>L263V</sup> is prevented by sodium channel blockade.
  9. Doxapram for the prevention and treatment of apnea in preterm infants.
  10. [Comparison of the efficacy of domestic and imported caffeine citrate in the treatment of apnea in preterm infants: a prospective randomized double-blind controlled trial].